---
layout: splash
title: HLB생명과학 (067630)
excerpt: HLB생명과학의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 13,990 | <span style="color: cornflowerblue">-2.0<small>%</small></span> | Q:제약 | - | 6.0 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 의료용품 및 기타 의약 관련제품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | ESCO 사업, 신재생에너지 사업 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2008년 11월 25일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 남상우, 한용해(각자대표) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.hlb-ls.com](http://www.hlb-ls.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 02&#x2011;15 | | [신주인수권행사              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240215900810){:target="_blank"} |
| 02&#x2011;13 | | [매출액또는손익구조30%(대규모법인은15%)이상변동              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240213900867){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![067630](/stock/images/067630.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 13,990 | <span style="color: cornflowerblue">-2.0<small>%</small></span> | <span style="color: cornflowerblue">-18.5<small>%</small></span> | <span style="color: tomato">37.8<small>%</small></span> | <span style="color: tomato">54.2<small>%</small></span> | <span style="color: tomato">57.2<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">28.5<small>%</small></span> | 48.8<small>%</small> | 0.58 | -32.8<small>%</small> | -18.0<small>%</small> | -0.9 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | - | 6.0 | - | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/067630/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=067630){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A067630&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=067630){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/067630){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/067630/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![067630](/stock/images/067630_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 28.5<small>%</small> | 48.8<small>%</small> | 0.58 | -32.8<small>%</small> | -18.0<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 37.0<small>%</small> | 46.8<small>%</small> | 0.79 | -26.3<small>%</small> | -13.7<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -35.2<small>%</small> | 34.5<small>%</small> | -1.02 | -43.4<small>%</small> | -24.7<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 33.8<small>%</small> | 36.0<small>%</small> | 0.94 | -32.1<small>%</small> | -19.0<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -5.1<small>%</small> | 37.2<small>%</small> | -0.14 | -33.0<small>%</small> | -19.8<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -16.1<small>%</small> | 38.6<small>%</small> | -0.42 | -45.6<small>%</small> | -32.6<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 3.0<small>%</small> | 35.5<small>%</small> | 0.08 | -30.8<small>%</small> | -21.7<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 0.3<small>%</small> | 31.9<small>%</small> | 0.01 | -26.4<small>%</small> | -17.3<small>%</small> |
| MACD[^fn_tech_metric_macd] | -34.0<small>%</small> | 38.1<small>%</small> | -0.89 | -50.2<small>%</small> | -32.0<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![067630](/stock/images/067630_corr.png){: .align-center}

|       | [커넥트웨이브](/119860/) | [SK](/034730/) | [HLB](/028300/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [에이비엘바이오](/298380/) | [넷마블](/251270/) | [녹십자홀딩스](/005250/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![067630](/stock/images/067630_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}